Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

This study was designed to retrospectively evaluate the efficacy and safety of modified FOLFOX-6 regimen in advanced gastric cancer (AGC) patients with poor performance status (PS). From January 2005 to August 2010, 23 AGC patients with poor PS who received mFOLFOX-6 as first-line chemotherapy were...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: KIM, HYEONG SU, KIM, JUNG HAN, KIM, HEE JUN, JANG, HYUN JOO, KIM, JIN BAE, KIM, JI WON, JUNG, SO YOUNG, KIM, BYUNG CHUN, YANG, DAE HYUN, PARK, SOAH, KIM, KEONG JU, LEE, SOON IL, ZANG, DAE YOUNG
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2012
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362383/
https://ncbi.nlm.nih.gov/pubmed/22740925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.496
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires